Bristol-Myers Squibb News, Bristol-Myers Squibb Quote, BMY Quote

Bristol-Myers Squibb (NY:BMY) Delayed: 62.63 -0.21 (0.33%)

Prev. Close

$62.84

Today 6M 1Y 5Y

Open

$62.71

52 Wk High

$77.12

52 Wk Low

$49.03

Day High

$62.96

Day Low

$62.19

P/E

40.67

EPS

$1.54

Volume

4,294,216

Friends, Peers and Foes (?): PFE, BMS, LLY, MRK, ABBV (more...)

ALERTS | RSS

Sep 18, 2026 06:59 AM Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026
Sep 17, 2026 04:00 PM Faeth Therapeutics adds cancer biologist Karen Vousden to its board
Sep 17, 2026 06:59 AM BMS Sotyktu shows sustained efficacy in psoriatic arthritis at two years
Sep 17, 2026 06:59 AM Bristol Myers Squibb Presents Sotyktu (deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis Over Two Years
Sep 17, 2026 06:00 AM Buy the pullback in this large pharma stock: UBS
Sep 16, 2026 06:59 AM Bristol-Myers Squibb (BMY) Declares $0.63 Quarterly Dividend; 4% Yield
Sep 16, 2026 06:59 AM Bristol Myers Squibb Announces Dividend
Sep 16, 2026 06:49 AM Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
Sep 10, 2026 04:37 PM Form 4 BRISTOL MYERS SQUIBB CO For: Sep 09 Filed by: Massacesi Cristian
Sep 10, 2026 08:30 AM Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market

Entities mentioned with BMY

View All Entities